BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2664620)

  • 21. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis.
    Martínez S; Garrido N; Coperias JL; Pardo F; Desco J; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2007 Mar; 22(3):836-42. PubMed ID: 17062580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical presentation and diagnosis of endometriosis.
    Galle PC
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):29-42. PubMed ID: 2664621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
    Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE
    Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis.
    Kurdoglu Z; Gursoy R; Kurdoglu M; Erdem M; Erdem O; Erdem A
    Fertil Steril; 2009 Nov; 92(5):1761-3. PubMed ID: 19631319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA 125, NB/70K, and lipid-associated sialic acid in monitoring uterine papillary serous carcinoma.
    Tseng PC; Sprance HE; Carcangiu ML; Chambers JT; Schwartz PE
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):384-7. PubMed ID: 2761916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
    van Dalen A; Kessler AC
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis.
    Matalliotakis IM; Goumenou AG; Mulayim N; Karkavitsas N; Koumantakis EE
    Arch Gynecol Obstet; 2005 Jan; 271(1):40-5. PubMed ID: 15243756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CA 125 and conventional examinations in diagnosing progressive carcinoma of the ovary.
    van der Burg ME; Lammes FB; Verweij J
    Surg Gynecol Obstet; 1993 Apr; 176(4):310-4. PubMed ID: 8460404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluctuations of tumor markers in heart failure patients pre and post heart transplantation.
    Nägele H; Bahlo M; Klapdor R; Rödiger W
    Anticancer Res; 1999; 19(4A):2531-4. PubMed ID: 10470189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of CA-125 in the diagnosis and management of endometriosis.
    Pittaway DE; Fayez JA
    Fertil Steril; 1986 Nov; 46(5):790-5. PubMed ID: 3465595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
    Plante M; Wong GY; Nisselbaum JS; Almadrones L; Hoskins WJ; Rubin SC
    Obstet Gynecol; 1993 Jun; 81(6):989-92. PubMed ID: 8497368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons.
    Falconer H; Bambra CS; Chai D; Cornillie FJ; Hill JA; D'Hooghe TM
    Hum Reprod; 2005 Nov; 20(11):3033-8. PubMed ID: 16037112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA 50: a tumor marker for gastrointestinal malignancies.
    Bunworasate U; Voravud N
    J Med Assoc Thai; 1995 May; 78(5):255-70. PubMed ID: 7561549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme-linked immunosorbent assay of CA-125 in serum of patients with endometriosis: efficacy in diagnosis.
    Kang JO; Hudak WA; Keller N; Criswell BS
    Clin Chem; 1988 Oct; 34(10):1983-6. PubMed ID: 3168208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CA-125 in menstrual discharge in patients with chronic pelvic pain.
    Abu-Musa A; Takahashi K; Nagata H; Yamasaki H; Mizoguchi S; Kitao M
    Int J Gynaecol Obstet; 1992 Feb; 37(2):111-4. PubMed ID: 1348698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endometriosis: review of the literature and clinical management].
    Wenger JM; Loubeyre P; Marci R; Dubuisson JB
    Rev Med Suisse; 2009 Oct; 5(222):2085-6, 2088-90. PubMed ID: 19947450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial antibodies versus CA-125 for the detection of endometriosis.
    Wild RA; Hirisave V; Bianco A; Podczaski ES; Demers LM
    Fertil Steril; 1991 Jan; 55(1):90-4. PubMed ID: 1986975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple serum marker assay in the diagnosis of endometriosis.
    Muscatello R; Cucinelli F; Fulghesu A; Lanzone A; Caruso A; Mancuso S
    Gynecol Endocrinol; 1992 Dec; 6(4):265-9. PubMed ID: 1492582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.